Table 2.
Allele and genotype frequencies of SLCO1B1 in patients taking aspirin
| Gene | Allele frequencies p† value for HWE | Control n = 250(%) |
Case n = 286 (%) |
p | Genotype | Control n = 125 (%) |
Case n = 143 (%) |
p |
|---|---|---|---|---|---|---|---|---|
| SLCO1B1 | A = 0.28 | 78 (31.2) | 74 (25.9) | 0.172 | AA | 9 (7.2) | 10 (7.0) | 0.947 |
| 388 A > G | G = 0.72 | 172 (68.8) | 212 (74.1) | AG | 60 (48) | 54 (37.8) | 0.091 | |
| rs2306283 | P† = 0.44 | GG | 56 (44.8) | 79 (55.2) | 0.088 | |||
| SLCO1B1 | T = 0.79 | 180 (72.0) | 245 (85.7) | <0.001 | TT | 73 (58.4) | 111 (77.6) | 0.001 |
| 521 T > C | C = 0.21 | 70 (28.0) | 41 (14.3) | TC | 34 (27.2) | 23 (16.1) | 0.027 | |
| rs4149056 | P† = 0.37 | CC | 18 (14.4) | 9 (6.3) | 0.028 |
p values from the Chi-squared test. †, Hardy–Weinberg equilibrium (HWE) of allele frequencies at individual loci was assessed by comparing the observed and expected genotype frequencies